Proteogenix
Schiltigheim, Grand Est
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- International Organization
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 19 Rue de la Haye, 67300 Schiltigheim, France
- Website
- proteogenix.science
- Founded
- 2003
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $48,250 |
| FY2024 | $75,960 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Vector Biomed Inc. | Gaithersburg, MD | 325414 Biological Product (except Diagnostic) Manufacturing |
| Genscript Probio USA Inc. | Pennington, NJ | 325414 Biological Product (except Diagnostic) Manufacturing |
| IDT Biologika GMBH | Dessau-Roßlau, SA | 325414 Biological Product (except Diagnostic) Manufacturing |
| Editco Bio Inc. | Redwood City, CA | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| Invvax, Inc. | Cypress, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Proteogenix is a for-profit biotechnology manufacturer based in Schiltigheim, France, with international organizational status. Registered in SAM.gov since August 2020 and valid through February 2026, the company specializes in advanced biotechnological services and products. While limited publicly available information exists about the company's comprehensive background, their federal contract awards demonstrate expertise in sophisticated laboratory screening and research support services.
Proteogenix has exclusively worked with the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health, on multiple purchase order contracts focused on gene therapy research. Their specific services have included phage-display library screening, VHH antibody screening, and laboratory screening services to support genetic analysis and gene modification experiments. These contracts, ranging from $10,620 to $46,260, have been awarded through full and open competition with no specific set-aside designations. The contracts consistently target advanced research objectives, particularly in developing hematopoietic stem cell (HSC) therapy and in vivo gene therapy methodologies. All contracts have been structured as firm fixed-price purchase orders with completion dates between April and November 2025, indicating Proteogenix's ongoing collaborative relationship with NHLBI's Cellular and Molecular Therapeutics Laboratory and Center for Molecular Therapeutics and Bioanalytics.
Quick answers
Is Proteogenix registered in SAM.gov?
Yes. Proteogenix's SAM.gov registration is active through February 16, 2027.
What is Proteogenix's CAGE code?
Proteogenix's CAGE code is FBFY6, and its Unique Entity ID (UEI) is CP2GCU4XTVM7.
How much has Proteogenix received in federal contracts?
Federal contracts obligated $48,250 to Proteogenix in fiscal year 2025 and $124,210 in fiscal years 2023 through 2027.
How does Proteogenix rank among federal contractors?
Proteogenix ranked #67 in NAICS 325414 in FY2025.
What is Proteogenix's most recent federal award?
Proteogenix's most recent federal contract award is [25-013787] nhlbi cellular and molecular therapeutics laboratory requires the phage library in order to perform… (75N92025P00347), from National Heart Lung and Blood Institute (NIH), on August 28, 2025.
On GovTribe
See Proteogenix's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors